Covered recipient · General Payments record
SANDRA CAROLE STUBBLEFIELD
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$4,553.01
- Reported across 322 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $509.29 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $292.40 | 23 |
| Acerta Pharma LLC | $69.51 | 4 |
| GlaxoSmithKline, LLC. | $62.80 | 4 |
| PFIZER INC. | $47.39 | 3 |
| Abbott Laboratories | $22.96 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.96 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124906124 | CMS |
| ABBVIE INC. | $4.09 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175358 | CMS |
| ABBVIE INC. | $12.20 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175360 | CMS |
| ABBVIE INC. | $17.21 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175362 | CMS |
| ABBVIE INC. | $19.42 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175364 | CMS |
| ABBVIE INC. | $3.26 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175366 | CMS |
| ABBVIE INC. | $1.57 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175368 | CMS |
| ABBVIE INC. | $15.91 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175370 | CMS |
| ABBVIE INC. | $14.86 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175372 | CMS |
| ABBVIE INC. | $2.22 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175374 | CMS |
| ABBVIE INC. | $2.40 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175376 | CMS |
| ABBVIE INC. | $34.29 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175378 | CMS |
| ABBVIE INC. | $16.67 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175380 | CMS |
| ABBVIE INC. | $15.94 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175382 | CMS |
| ABBVIE INC. | $5.75 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175384 | CMS |
| ABBVIE INC. | $15.91 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175386 | CMS |
| ABBVIE INC. | $15.62 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175388 | CMS |
| ABBVIE INC. | $5.90 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175390 | CMS |
| ABBVIE INC. | $33.28 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175392 | CMS |
| ABBVIE INC. | $22.27 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175394 | CMS |
| ABBVIE INC. | $4.64 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175396 | CMS |
| ABBVIE INC. | $11.74 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175398 | CMS |
| ABBVIE INC. | $7.90 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175400 | CMS |
| ABBVIE INC. | $9.35 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175402 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.75 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104327746 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.31 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104383371 | CMS |
| AstraZeneca Pharmaceuticals LP | $27.56 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105501326 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.89 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105825225 | CMS |
| GlaxoSmithKline, LLC. | $15.15 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116356323 | CMS |
| GlaxoSmithKline, LLC. | $13.67 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116032532 | CMS |
| GlaxoSmithKline, LLC. | $18.01 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116290751 | CMS |
| GlaxoSmithKline, LLC. | $15.97 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116472773 | CMS |
| PFIZER INC. | $15.10 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130947306 | CMS |
| PFIZER INC. | $17.76 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131224542 | CMS |
| PFIZER INC. | $14.53 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131886361 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.23 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137683341 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.